This phase 3, randomized, controlled, partially blinded interventional study evaluates the antitumor activity of pembrolizumab, pembrolizumab plus chemotherapy, or chemotherapy alone in patients with untreated, advanced gastric/gastroesophageal junction cancer with PD-L1 combined positive score ≥1.
This quality improvement study investigates usage patterns of codes for inflammatory arthritides under International Statistical Classification of Diseases and Related Health Problems, Tenth Revision vs…
This case-control study of US military service members examines the sensitivity of 2 imaging techniques targeting white matter microstructure for diagnosis and prognosis of outcomes…
This multicenter diagnostic study determines the intermodality variability of left ventricular ejection fraction (LVEF) measured by echocardiography, gated single-photon emission computed tomography (SPECT), and cardiovascular…
This cohort study evaluates if neighborhood disadvantage is associated with shorter breast cancer–specific survival after controlling for individual, tumor, and treatment characteristics in a national…
This cross-sectional study investigates the frequency and intensity of somatic symptoms in children and adolescents who experienced traumatic events.
This report describes the development of an 18-gene urine panel for high-grade prostate cancer and validates its external performance relative to current guideline-endorsed biomarkers.
This study compares 2 large language models and their performance vs that of competing open-source models.
This cohort study examines respiratory syncytial virus (RSV) among infants and children and assesses differences in hospital use overall, hospital use by care unit, and…
This cohort study evaluates the association between racial discrimination and metabolic syndrome in rural US Black individuals transitioning from late adolescence into early adulthood and…
This report describes the development of an 18-gene urine panel for high-grade prostate cancer and validates its external performance relative to current guideline-endorsed biomarkers.
